Exelon sets up $2.5 billion at-the-market stock sale program
On May 2, 2025, Exelon entered into an Equity Distribution Agreement creating an at-the-market program to sell common stock with an aggregate gross sales price of up to $2.5 billion. The company has no obligation to sell any shares and may suspend or terminate the program at any time, and it expects to use any net proceeds for general corporate purposes, including repaying debt. Shares sold would dilute existing holders, so shareholders should note the potential increase in outstanding shares.
Key points
- Program size: aggregate gross sales price of up to $2,500,000,000 across sales agents and forward sellers
- Company expects proceeds from physical settlement of forward sale agreements, with use of proceeds for general corporate purposes including debt repayment
- Shares offered under Form S-3 Registration Statement No. 333-284911
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:30 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 02, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.